NDRG1 and prostate carcinoma: Pronounced nuclear localization of p-NDRG1 (Ser330) was observed by Park et al., which contrasts with the findings of Ladet et al. (62), who reported reduced nuclear localization of NDRG1 following Ser330 phosphorylation in LNCaP and VCaP prostate cancer cells.